Board-ready insights on quantum innovation · Biomedical discovery · Post-quantum transition
QUENTIR
A physician reviews a glowing molecular scan beside an adult patient in a calm clinical room

Quentir Universe · QEH-001

Hyper-personalized quantum healthcare

Medicine shaped to one patient’s own chemistry.

Open Horizon · far · ~2040 Founder conjecture — not a research finding

The call

stated plainly

By 2040, a quantum-enabled component — sensing, simulation, optimization, or machine learning, each kept distinct — demonstrates prospective clinical value in at least one narrowly defined patient-specific workflow, measured against the best available classical comparator.

Status
Open
Horizon
far · ~2040
First stated
2026-07-15
Evidence last checked
2026-07-16
Author
Mauritz Kop

Conviction

stated with numbers
  • DirectionMeaningful research continues and matures — high.
  • DeadlineA prospectively validated clinical result by 2040 — about 35%.

Observed · Inferred · Conjectured

the method, in the open
Observed

Wearable optically-pumped MEG already localizes pediatric epileptic activity in the clinic without sedation. AstraZeneca, AWS, IonQ and NVIDIA ran an end-to-end simulation of a real drug-synthesis step (Suzuki-Miyaura) on a 36-qubit machine, reporting a 20× cut in time-to-solution. Quantum biology reached an in-vivo milestone: spin-correlated radical-pair dynamics controlled in a living organism. The honest anchor stands beside these results: a 2025 PRISMA systematic review found no consistent empirical quantum advantage in digital health yet, with 81.7% of studies simulation-only.

Inferred

Sensing is the nearest clinical channel; simulation is advancing at proof-of-concept. The channels are real, funded, and peer-reviewed.

Conjectured

These channels converge into validated, per-patient clinical value. No claim of present clinical quantum advantage travels with this call.

The evidence trail

last checked 2026-07-16
  • Gupta et al., “A systematic review of quantum machine learning for digital health,” npj Digital Medicine 8:237 (2025) — the honest anchor: no consistent empirical quantum advantage yet. DOI
  • Lo Fiego et al., “How quantum biosensing is transforming healthcare,” Nature Reviews Physics 7:672 (2025). DOI
  • IonQ / AstraZeneca / AWS / NVIDIA computational-chemistry demonstration, ISC High Performance 2025 (vendor-reported numbers).
  • In-vivo control of spin-correlated radical-pair dynamics in a living organism, Nature (2026).

What would change this call

the register keeps the record
Raises confidence

A prospective, controlled clinical result where a quantum component beats the best classical comparator.

Lowers confidence

A decade of progress with no clinical endpoint reached.

The call fails if

No prospectively validated clinical workflow uses a quantum component by 2040.

In the Universe

layer one, underneath
Where this meets the evidence work This conjecture sits closest to Quentir’s evidence products. The free Quantum Medicine Monitor follows the clinical evidence as it lands, and the Quantum Medicine Evidence Register on the products page tracks every claim against its sources.

How this register works

The Quantum Event Horizon is a forward-looking register of founder conjectures at the frontier, held apart from Quentir’s evidence-based research products. Each entry rests on an evidence-based method: interdisciplinary research, trust-grounded data, and a plain statement of what is Observed, what is Inferred, and what is Conjectured. When the evidence moves, the entry moves: confidence rises, falls, or the call is closed — and the record of the change stays on the page.